Клиномир в тестовом запуске. Кто с нами с первых дней, получит отметку «С первых дней» в профиле и первым увидит новые возможности сайта.

Зарегистрироваться
Каталог · ЕАЭС

Клинические исследования и проекты

Sanofi · найдено 123

Sanofi
Ищем по всем вариантам написания в реестрах, по-русски и по-английски. Спонсор или разработчик.
Статус
Что исследуют
Источник
Фаза
Страна
Участники
Кто может участвовать По критериям ClinicalTrials.gov. Исследования, где реестр возраст и пол не указывает, тоже показываются. Возраст и пол нигде не сохраняются.
Сбросить
123 исследования
Завершено Фаза III Беларусь
Idrabiotaparinux sodium; Warfarin; Placebo (for idrabiotaparinux sodium); Avidin; Placebo (for warfarin); Enoxaparin · Sanofi

An International, Multicenter, Randomized, Double-blind, Double-dummy, Parallel Group, Study of 3-month or 6-month Treatment With SSR126517E (3.0 mg s.c. Once-weekly) Versus Oral INR-adjusted Warfarin in the Treatment of Patients With Symptomatic Pulmonary Embolism With or Without Symptomatic Deep Venous Thrombosis

3 202 участника во всех странах ClinicalTrials.gov EFC6034
Завершено Фаза III Беларусь
Semuloparin sodium; Enoxaparin; Placebo · Sanofi

A Multinational, Multicenter, Randomized, Double-blind Study Comparing the Efficacy and Safety of Semuloparin (AVE5026) With Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Elective Knee Replacement Surgery

1 150 участников во всех странах ClinicalTrials.gov EFC10571
Завершено Фаза IV Беларусь
INSULIN GLULISINE (HMR1964); INSULIN GLARGINE · Sanofi

Multicentre, Open, Non-randomised Controlled Phase IV Clinical Trial of Efficacy and Safety for Insulin Glulisine Injected Subcutaneously in Patients With Type 1 Diabetes Mellitus Using Also Insulin Glargine

68 участников во всех странах ClinicalTrials.gov APIDR_L_02483
Завершено Фаза III Беларусь
Semuloparin sodium; Enoxaparin sodium; Placebo · Sanofi

A Multinational, Multicenter, Randomized, Double-Blind Study Comparing the Efficacy and Safety of AVE5026 With Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery

2 326 участников во всех странах ClinicalTrials.gov EFC10342
Завершено Фаза III Беларусь
Otamixaban; Placebo (for Otamixaban); UFH; Placebo (for UFH); Eptifibatide; Placebo (for Eptifibatide) · Sanofi

Randomized, Double-blind, Triple-dummy Trial to Compare the Efficacy of Otamixaban With Unfractionated Heparin + Eptifibatide, in Patients With Unstable Angina/Non ST Segment Elevation Myocardial Infarction Scheduled to Undergo an Early Invasive Strategy

13 220 участников во всех странах ClinicalTrials.gov EFC6204
Прекращено Фаза III Беларусь
Idrabiotaparinux sodium; Warfarin; Placebo (for idrabiotaparinux); Placebo (for warfarin); Avidin; Placebo (for avidin) · Sanofi

A Multicenter, Randomized, Double-blind, Assessor-blind, Non-inferiority Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous Biotinylated Idraparinux (SSR126517E) With Oral Adjusted-dose Warfarin in the Prevention of Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation

3 773 участника во всех странах ClinicalTrials.gov EFC10295
Завершено Фаза III Беларусь
Enoxaparin sodium; Semuloparin sodium; Placebo · Sanofi

A Multinational, Multicenter, Randomized, Double-Blind Study Comparing the Efficacy and Safety of AVE5026 With Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Hip Fracture Surgery

1 003 участника во всех странах ClinicalTrials.gov EFC10343
Завершено Фаза III Казахстан
CABAZITAXEL · Sanofi

Multicentre, Single-arm, Open Label Clinical Trial Intended to Provide Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen and to Document Safety of Cabazitaxel in These Patients

984 участника во всех странах ClinicalTrials.gov CABAZ_C_05331
Завершено Фаза IV Казахстан
Insulin Glulisine · Sanofi

Local, Open, Non-Randomized, Phase IV Clinical Study for the Collection of Data Regarding the Drug Portability Received During the Treatment With Subcutaneous Injection of Apidra Glulisine (HMR1964) to Patients With Diabetes Mellitus 1st Type

Алматы 1 центр 45 участников во всех странах ClinicalTrials.gov APIDR_L_00041
Завершено Фаза IV Казахстан
GLIMEPIRIDE + METFORMIN · Sanofi

AMIT Study - Amaryl M Initiation and Titration Study

172 участника во всех странах ClinicalTrials.gov GLMET_L_04718
Завершено Фаза III Россия
Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®); Placebo; Docetaxel (Taxotere®); Dexamethasone (pre- and post-medication for docetaxel) · Sanofi

A Multinational, Randomized, Double-Blind Study Comparing Aflibercept Versus Placebo in Patients Treated With Second-Line Docetaxel After Failure of One Platinum Based Therapy for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

913 участников во всех странах ClinicalTrials.gov EFC10261
Завершено Фаза III Россия
Semuloparin sodium; Placebo (for semuloparin) · Sanofi

A Multinational, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AVE5026 in the Prevention of Venous Thromboembolism (VTE) in Cancer Patients at High Risk for VTE and Who Are Undergoing Chemotherapy

3 212 участников во всех странах ClinicalTrials.gov EFC6521
Прекращено Фаза III Россия
Rimonabant; Placebo (for Rimonabant) · Sanofi

Randomized, Multinational, Multicenter, Double-blind, Placebo-controlled, Two-arm Parallel Group Trial of Rimonabant 20 mg OD for Reducing the Risk of Major Cardiovascular Events in Abdominally Obese Patients With Clustering Risk Factors

18 695 участников во всех странах ClinicalTrials.gov EFC5826
Завершено Фаза II Россия
SL650472, Clopidogrel · Sanofi

Double-Blind, Double-Dummy, Randomized, Parallel Group Trial of SL650472 (Three Dose Regimens Versus Placebo and Cilostazol), for 24-Week Improvement of Walking Distance in Patients With Stage II Peripheral Arterial Disease Who Benefit From Optimal Prevention Strategy Including Clopidogrel

599 участников во всех странах ClinicalTrials.gov ACT4791
Завершено Фаза III Россия
Clopidogrel; acetylsalicyclic acid (ASA) · Sanofi

Randomized, Multinational, Double-blind Study, Comparing a High Loading Dose Regimen of Clopidogrel Versus Standard Dose in Patients With Unstable Angina or Myocardial Infarction Managed With an Early Invasive Strategy.

25 086 участников во всех странах ClinicalTrials.gov EFC5965
Завершено Фаза III Россия
Insulin glargine (HOE901); Neutral Protamine Hagedorn (NPH) insulin; Insulin lispro · Sanofi

A 24-week, Randomized, Open-label, Parallel Group Multinational Comparison of Lantus® (Insulin Glargine) Given in the Morning as Once-a-day Basal Insulin Versus Neutral Protamine Hagedorn (NPH) Insulin, in Children With Type 1 Diabetes Mellitus Aged at Least 1 Year to Less Than 6 Years

125 участников во всех странах ClinicalTrials.gov EFC11202
Завершено Фаза III Россия
Idrabiotaparinux sodium; Warfarin; Placebo (for idrabiotaparinux sodium); Avidin; Placebo (for warfarin); Enoxaparin · Sanofi

An International, Multicenter, Randomized, Double-blind, Double-dummy, Parallel Group, Study of 3-month or 6-month Treatment With SSR126517E (3.0 mg s.c. Once-weekly) Versus Oral INR-adjusted Warfarin in the Treatment of Patients With Symptomatic Pulmonary Embolism With or Without Symptomatic Deep Venous Thrombosis

Москва 1 центр 3 202 участника во всех странах ClinicalTrials.gov EFC6034
Завершено Фаза III Россия
Semuloparin sodium; Enoxaparin; Placebo · Sanofi

A Multinational, Multicenter, Randomized, Double-blind Study Comparing the Efficacy and Safety of Semuloparin (AVE5026) With Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Elective Knee Replacement Surgery

1 150 участников во всех странах ClinicalTrials.gov EFC10571
Завершено Фаза III Россия
Placebo; Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®); FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin); FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) · Sanofi

A Multinational, Randomized, Double-blind Study, Comparing the Efficacy of Aflibercept Once Every 2 Weeks Versus Placebo in Patients With Metastatic Colorectal Cancer (MCRC) Treated With Irinotecan / 5-FU Combination (FOLFIRI) After Failure of an Oxaliplatin Based Regimen

1 226 участников во всех странах ClinicalTrials.gov EFC10262

Изменения не сохранены

На этой странице есть несохранённые изменения. Если уйти со страницы, они пропадут.